Alla Patlis - 11 Mar 2024 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Interim Chief Financial Officer & Controller
Signature
/s/ Alla Patlis
Issuer symbol
BCLI
Transactions as of
11 Mar 2024
Net transactions value
$0
Form type
4
Filing time
13 Mar 2024, 20:55:55 UTC
Previous filing
02 Sep 2021
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +65,246 $0.000000 65,246 11 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The grant of restricted stock awards ("RSAs") to the Reporting Person as reported herein was approved by the board of directors of the Issuer on March 11, 2024 ("Grant Date") as part of the Issuer's grant of equity awards in the ordinary course. The RSAs shall vest in equal yearly installments over the course of two (2) years, with vesting occurring on each of the first and second anniversary of the Grant Date.

Remarks:

Interim Chief Financial Officer & Controller